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Diagnosis of cardiac structural changes:  
Utility of altered gadolinium kinetics  
on cardiac magnetic resonance
We read with great interest the article by Dwi-
vedi et al. [1] entitled “Progressive breathlessness 
in an Afro Caribbean hypertensive subject”, which 
was published in the previous issue of ”Cardiology 
Journal”.
They aimed to show diagnostic utility of hyper-
-enhancement patterns on cardiac magnetic reso-
nance (CMR) in differentiating a range of structural 
changes that manifest as increased wall thickness. 
They also mentioned that primary cardiac amylo-
idosis could not be excluded on the basis of the 
T1 mapping findings. This case highlights the 
diagno stic abilities of CMR in questionable cases, 
yet we have some comments about the article.
In addition to the enhancement pattern, myo-
cardial tagging magnetic resonance images can 
show any active displacement and deformation of 
tags in regions conflicting with septal hypertrophy.
In amyloid patients, differences in T1 between 
subepicardium, myocardium, subendocardium, and 
blood are present. Gadolinium washout from blood 
and myocardium is significantly faster in amyloid 
patients, resulting in a higher blood T1 over time 
[2, 3].
In conclusion, late gadolinium enhancement 
provides incremental information for differentia-
ting a range of structural changes. Subendocardial 
T1 over time is significantly lower than blood and 
myocardium ones, and diagnosis can be established 
using the combination of enhancement pattern and 
subendocardial-blood T1 difference with > 90% 
concordance.
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